In 486 patients with endometrial cancer whose tumor samples were tested for L1CAM (clone 14.10, dilution 1:200, cutoff 10%), 53% of tumors expressed L1CAM—a higher percentage than most previous studies mentioned above, probably explained by including high-risk patients in this study [68]. Here, L1CAM is linked to neoplasm.